Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jens H.W. Pahl"'
Autor:
Adelheid Cerwenka, Martin Treder, Erich Rajkovic, Thorsten Gantke, Uwe Reusch, Annette Arnold, Jana-Julia Götz, Joachim Koch, Jens H.W. Pahl
CD16A is a potent cytotoxicity receptor on human natural killer (NK) cells, which can be exploited by therapeutic bispecific antibodies. So far, the effects of CD16A-mediated activation on NK cell effector functions beyond classical antibody-dependen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae3f8cbb51f9ad2483ec37cb1332000a
https://doi.org/10.1158/2326-6066.c.6548009.v1
https://doi.org/10.1158/2326-6066.c.6548009.v1
Autor:
Adelheid Cerwenka, Martin Treder, Erich Rajkovic, Thorsten Gantke, Uwe Reusch, Annette Arnold, Jana-Julia Götz, Joachim Koch, Jens H.W. Pahl
S1. NK cell cytotoxicity and IFNγ are enhanced by AFM13 towards different types of lymphoma cells. S2. Pre-activation by rituximab increases IL2-dependent NK cell proliferation and expansion. S3. Recovery of NK cell function by IL2 or IL15 after AFM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::386c564d785a74356393fe303d26f420
https://doi.org/10.1158/2326-6066.22535999.v1
https://doi.org/10.1158/2326-6066.22535999.v1
Autor:
R. Maarten Egeler, Eleni Maria Varypataki, Susan Mohamed, Susy J Santos, Arjan C. Lankester, Jens H.W. Pahl, Wim Jiskoot, Kitty M. C. Kwappenberg, Anne-Marie Cleton-Jansen, Juul T. Wijnen, Maarten J. D. van Tol, Marieke L. Kuijjer, Marco W. Schilham
Publikováno v:
Journal of Experimental & Clinical Cancer Research; Vol 33
Journal of Experimental and Clinical Cancer Research, 33
journal of experimental & clinical cancer research, 33(1), 27-40
Journal of Experimental & Clinical Cancer Research : CR
journal of experimental & clinical cancer research
Journal of Experimental and Clinical Cancer Research, 33
journal of experimental & clinical cancer research, 33(1), 27-40
Journal of Experimental & Clinical Cancer Research : CR
journal of experimental & clinical cancer research
Background In osteosarcoma, the presence of tumor-infiltrating macrophages positively correlates with patient survival in contrast to the negative effect of tumor-associated macrophages in patients with other tumors. Liposome-encapsulated muramyl tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ff52f59d9ccefe0680027340c0cb9de
https://hdl.handle.net/1887/104282
https://hdl.handle.net/1887/104282
Autor:
Massimo Serra, Arjan C. Lankester, M.W. Schilham, Susy J Santos, Karoly Szuhai, Hans Gelderblom, Jens H.W. Pahl, Pancras C.W. Hogendoorn, S. Eriaty N. Ruslan, Emilie P. Buddingh, R. Maarten Egeler
Publikováno v:
Clinical Cancer Research, 18(2), 432-441
Clinical Cancer Research, 18(2), 432-41
Clinical Cancer Research, 18(2), 432-41
Purpose: Osteosarcoma and Ewing's sarcoma are the most common bone tumors in children and adolescents. Despite intensive chemotherapy, patients with advanced disease have a poor prognosis, illustrating the need for alternative therapies. Sarcoma cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e045adccb4107613f6ce9bb667c7ec4b
https://pubmed.ncbi.nlm.nih.gov/22090361
https://pubmed.ncbi.nlm.nih.gov/22090361
Autor:
Anne-Marie Cleton-Jansen, Laurens G. L. Sand, R. Maarten Egeler, Susy J Santos, Judith V.M.G. Bovée, Arjan C. Lankester, Marieke L. Kuijjer, Marco W. Schilham, Gerharda H. Boerman, Karoly Szuhai, Jens H.W. Pahl
Publikováno v:
Cancer Cell International, 15
Cancer Cell International
Cancer Cell International
Osteosarcoma is the most frequent bone cancer in children and young adults. The outcome of patients with advanced disease is dismal. Exploitation of tumor-immune cell interactions may provide novel therapeutic approaches. CD70-CD27 interactions are i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef17f98eb000c7933ad3b534ccf924ba